Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 5, 2004 - Issue 7
Submit an article Journal homepage
35
Views
4
CrossRef citations to date
0
Altmetric
Review

An update on the management of chronic lymphocytic leukaemia

Karen WL Yee University of Texas MD Anderson Cancer Center, Section of Developmental Therapeutics, Department of Leukaemia, 1515 Holcombe Boulevard, Houston, TX 77030, USA
,
Susan M O’Brien University of Texas MD Anderson Cancer Center, Section of Developmental Therapeutics, Department of Leukaemia, 1515 Holcombe Boulevard, Houston, TX 77030, USA
&
Francis J Giles University of Texas MD Anderson Cancer Center, Section of Developmental Therapeutics, Department of Leukaemia, 1515 Holcombe Boulevard, Houston, TX 77030, USA. [email protected]
Pages 1535-1554 | Published online: 25 Feb 2005

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Karen WL Yee & Susan M O’Brien. (2006) Emerging drugs for chronic lymphocytic leukaemia. Expert Opinion on Emerging Drugs 11:1, pages 167-189.
Read now

Articles from other publishers (3)

Bin-Tao Huang, Qing-Chun Zeng, Wei-Hong Zhao, Bing-Sheng Li & Rui-lin Chen. (2014) How to determine post-FCR therapy for cytogenetic risk-tailored elderly patients with chronic lymphocytic leukemia, maintenance rituximab or observation. Medical Oncology 31:8.
Crossref
Karen Yee, Michael Keating & Susan O’Brien. 2008. Chronic Lymphocytic Leukemia. Chronic Lymphocytic Leukemia 141 164 .
. (2005) Current Awareness in Hematological Oncology. Hematological Oncology 22:4, pages 183-190.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.